Your browser doesn't support javascript.
loading
Biomonitoring Equivalents for glyphosate.
Hays, Sean M; Kirman, Christopher R; Flippin, Jennifer; Lopez, Theresa.
Afiliação
  • Hays SM; Summit Toxicology, LLC, Bozeman, MT, USA. Electronic address: shays@summittoxicology.com.
  • Kirman CR; Summit Toxicology, LLC, Bozeman, MT, USA.
  • Flippin J; Tetra Tech, Inc, Denver, CO, USA.
  • Lopez T; Tetra Tech, Inc, Denver, CO, USA.
Regul Toxicol Pharmacol ; 144: 105481, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37633328
ABSTRACT
One of the most widely used herbicides worldwide, glyphosate is registered for use in many agricultural and non-agricultural settings. Accordingly, regulatory authorities develop toxicology reference values (TRVs) to conduct risk assessments for potential exposures. Exposures to glyphosate are typically biomonitored via measures of glyphosate in urine. However, measured concentrations of glyphosate in urine, with units mg/L urine, cannot be directly interpreted using the available TRVs as they are presented in terms of daily intake levels (e.g. mg/kg-bw per day). In this evaluation, we review available health-based risk assessments and TRVs for glyphosate and derive Biomonitoring Equivalent (BE) values for interpretation of population biomonitoring data. Biomonitoring Equivalents (BEs) are defined as the concentration or range of concentrations of a chemical or its metabolite in a biological medium (blood, urine, human milk, etc.) that is consistent with an existing health-based TRVs such as a reference dose (RfD) or tolerable daily intake (TDI). The BE values derived in this manuscript are screening values that can help public health officials and regulators interpret glyphosate biomonitoring data.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article